00886cam0 2200277 450 E60020004479720200521091736.020090204d1972 |||||ita|0103 baitaITHegel oggiJohn Niemeyer Findlaycur. Lorenzo CalabiMilanoILI1972XVI,428 p.20 cmCampus18001LAEC000165342001 *Campus18Finday, John NiemeyerA600200052435070776743Calabi, LorenzoA600200052436070ITUNISOB20200521RICAUNISOBUNISOB10018145E600200044797M 102 Monografia moderna SBNM100000671Si18145acquistopregresso2UNISOBUNISOB20090204114436.020200521091716.0SpinosaHegel oggi1680125UNISOB02326nam 2200481 450 991031756940332120221017112909.0953-51-4268-2(CKB)4970000000098390(NjHacI)994970000000098390(oapen)https://directory.doabooks.org/handle/20.500.12854/57739(MiAaPQ)EBC30390249(Au-PeEL)EBL30390249(EXLCZ)99497000000009839020221017d2012 uy 0engur|||||||||||txtrdacontentcrdamediacrrdacarrierRecent Advances in Novel Drug Carrier Systems /edited by Ali Demir Sezer1st ed.IntechOpen2012Rijeka, Croatia :IntechOpen,2012.1 online resource (x, 514 pages) illustrations953-51-0810-7 Includes bibliographical references.This contribution book collects reviews and original articles from eminent experts working in the interdisciplinary arena of novel drug delivery systems and their uses. From their direct and recent experience, the readers can achieve a wide vision on the new and ongoing potentialities of different drug delivery systems. Since the advent of analytical techniques and capabilities to measure particle sizes in nanometer ranges, there has been tremendous interest in the use of nanoparticles for more efficient methods of drug delivery. On the other hand, this reference discusses advances in the design, optimization, and adaptation of gene delivery systems for the treatment of cancer, cardiovascular, pulmonary, genetic, and infectious diseases, and considers assessment and review procedures involved in the development of gene-based pharmaceuticals.BiodegradationCongressesToxicology and Pharmaceutical SciencePharmaceutical DrugPharmacologyHealth SciencesBiodegradation620.1Ali Demir Sezerauth1366149Sezer Ali DemirNjHacINjHaclBOOK9910317569403321Recent Advances in Novel Drug Carrier Systems3389272UNINA01335nam 2200421 450 991015042260332120230808200504.03-95485-837-1(CKB)3710000000943402(MiAaPQ)EBC4741693(EXLCZ)99371000000094340220161207h20162016 uy 0gerurcnu||||||||rdacontentrdamediardacarrierAufbau einer Bio-Handelsmarke in der Drogeriebranche Chancen und Risiken im Category Management /Philipp VoshegeHamburg, [Germany] :Igel Verlag RWS,2016.©20161 online resource (107 pages) illustrations (some color)3-95485-337-X Includes bibliographical references.Pharmaceutical industryPurchasingIndustrial procurementBusiness logisticsPharmaceutical industryPurchasing.Industrial procurement.Business logistics.338.476151Voshege Philipp1375297MiAaPQMiAaPQMiAaPQBOOK9910150422603321Aufbau einer Bio-Handelsmarke in der Drogeriebranche3409561UNINA